According to Cantel Medical, PuriCore International will be renamed Cantel Medical (UK) and will be reported as part of the company’s Endoscopy segment.

Cantel Medical claims that this transaction further enhances the company’s global leadership of automated endoscope reprocessing and provides it with additional resources and capabilities to execute on its broader international strategy.

Cantel Medical COO and Medivators president Jorgen Hansen said this acquisition is an exciting step in the execution of its international strategy.

"The addition of the PuriCore endoscopy business to Medivators will meaningfully strengthen our offering in automated endoscope reprocessing while also enhancing our international capabilities and competitiveness," Hansenadded.

"We are excited to welcome the entire PuriCore International workforce to the Cantel family, and we look forward to working together toward delivering infection prevention and control solutions to patients and customers worldwide."